University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,742 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
982 of 1,090 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,423 total, page 12 of 29
A Peer-Led Intervention to Improve Postpartum Retention in HIV Care
NCT04168008
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393
18F-FluorThanatrace (PET/CT) in Glioblastoma
NCT04221061
Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Alzheimer Disease
NCT04482179
Developing Oral LT3 Therapy for Heart Failure - HFrEF
NCT04112316
Effect of PARP Inhibitors on Glomerular Filtration Rate
NCT04367467
Ob/Gyn Residency Podcast Curriculum
NCT04933071
Testing the Influence of Different Sugary Drink Warning Label Designs
NCT03648138
Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)
NCT03970200
Fruits and Vegetables Incentives Study
NCT04235413
Improving Aging in Place in Subsidized Housing
NCT04212442
Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection
NCT03973697
Lactation Achievement With Texts at Home
NCT04108533
Low Dose Fat-Induced Insulin Resistance
NCT03479671
Neurocognitive Benefits of a Weight Management Program
NCT04202133
FITBIT Study on Mobility and Readmissions After Radical Cystectomy
NCT04314778
Effect of rTMS on Anxiety
NCT03993509
Acceptability and Efficacy of the Zemedy App for Irritable Bowel Syndrome
NCT04170686
Perspectives on Prophylactic Antibiotic Use in Dermatologic Surgery
NCT04150523
Antibiotic Adherence Practices in Dermatologic Surgery
NCT04117724
Randomized Clinical Trial to Increase Physical Activity After a a Hypertensive Pregnancy
NCT04119232
Hypnosis for Bladder Pain Syndrome
NCT04010513
Molecular Imaging of the Underlying Mechanism of Cardiotoxicity in Patients With Light Chain Amyloidosis Using PET/CT
NCT04105634
Tracking and Improving Trust/Respect
NCT04392336
First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)
NCT04037397
Commensal Oral Microbiota in Head and Neck Cancer
NCT03843554
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
NCT03365635
Use of Virtual Reality for Overdose Management Educational Trainings
NCT04091659
Nurtured in Nature
NCT04146025
Bone Regenerative Techniques in Endodontic Microsurgery
NCT04514991
A Randomized Trial of Behavioral Economic Approaches to Reduce Unnecessary Opioid Prescribing
NCT03825549
Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment
NCT04073992
Move to Improve Physical Activity in Parkinson's Disease
NCT04051151
Improving Self-care of Heart Failure Caregivers
NCT03988621
Magnetic Stimulation to Treat VT Storm
NCT04043312
Pitocin or Oral Misoprostol for PROM IOL
NCT04028765
Rapid Initiation of Drug Treatment Engagement
NCT03908437
Use of Medication to Improve Weight Loss in Suboptimal Early Responders to Behavioral Treatment
NCT03779048
Machine-Generated Mortality Estimates and Nudges to Promote Advance Care Planning Discussion Among Cancer Patients
NCT03984773
Post-op Crowd Sourcing Health Data Via Text-messaging
NCT03532256
Voices Of Individuals: Challenges and Experiences Of bvFTD
NCT04060082
Time Restricted Eating Pilot - Bariatrics
NCT04006366
Vessel Wall MR Imaging to Explore Sex-Differences of Intracranial Arterial Wall Changes After Suspected Stroke
NCT03990545
Plan and Pledge, HIV Self-testing in South Africa
NCT03898557
Medication Adherence and Outcomes Among Patients in United States With HIV
NCT03995745
Using Digital Health, Financial Incentives, and Community Health Worker Support to Change Health Behavior
NCT03939793
Towards Predicting the Analgesic Response to Ibuprofen Following Third-molar Extraction
NCT03893175
Comparative Effectiveness of Financial Incentives and Nudges to Reduce Cellphone Use While Driving Among UBI Auto Policy Holders
NCT03833219
Cholate Clearance in Fontans
NCT03726229
Evaluation of SmartSleep Technology for Improving the Efficiency and Restorative Quality of Sleep in Healthy Adults
NCT03911154
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Pennsylvania: open-pipeline peers nationwide
Peers matched on 1,423 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
University of Pennsylvania sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,423 trials (± recruiting share)
- Johns Hopkins University · 1,448 trials · 17% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
- Yale University · 1,492 trials · 17% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Seattle Institute for Biomedical and Clinical Research · 14% recruiting · 43 trials
- University of Illinois at Urbana-Champaign · 14% recruiting · 129 trials
- Johns Hopkins Bloomberg School of Public Health · 14% recruiting · 187 trials
- Milton S. Hershey Medical Center · 14% recruiting · 396 trials
Related
What to do with this University of Pennsylvania page
1,423 registered trials is a research-attention snapshot, not an endorsement of University of Pennsylvania or any single study.
- 199 of University of Pennsylvania's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Pennsylvania studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Pennsylvania pipeline card: 1,423 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.